Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-30e-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 1212, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
NUFIP2 hsa-miR-30e-3p low: 0 high: 16 5 4 3 -
High-throughput experiments (16 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr17:29264351-29264368 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29261887-29261909 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29261439-29261466 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258838-29258859 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258594-29258620 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr17:29261439-29261466 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258838-29258859 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258838-29258859 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:29258838-29258859 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258838-29258859 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:29258838-29258859 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258838-29258859 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:29258838-29258859 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29257451-29257471 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Hafner M. et al. 2010 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN PAR-CLIP POSITIVE DIRECT TarBase 6.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29261887-29261909 PAR-CLIP POSITIVE DIRECT TarBase 7.0
AHNAK hsa-miR-30e-3p low: 0 high: 16 4 6 3 -
High-throughput experiments (16 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:62518378-62518404 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62527774-62527794 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62525113-62525141 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62524005-62524032 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62517293-62517313 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62531488-62531510 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62525113-62525141 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62533843-62533862 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62533255-62533280 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62532964-62532991 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62526265-62526289 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62524219-62524245 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62533255-62533280 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62529649-62529674 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62527774-62527794 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62521009-62521033 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDKN1B hsa-miR-30e-3p low: 0 high: 10 4 5 4 0.889
High-throughput experiments (10 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:12721138-12721163 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:12721138-12721163 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:12721138-12721163 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12722103-12722123 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DDX17 hsa-miR-30e-3p low: 0 high: 8 6 8 6 0.842
High-throughput experiments (8 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr22:38484376-38484401 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr22:38485283-38485305 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATL3 hsa-miR-30e-3p low: 0 high: 7 5 6 4 0.853
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:63628483-63628503 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr11:63628385-63628406 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr11:63627272-63627292 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:63628385-63628406 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:63628385-63628406 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr11:63628385-63628406 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:63628385-63628406 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HIVEP1 hsa-miR-30e-3p low: 0 high: 7 2 2 1 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr6:12120962-12120984 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:12120962-12120984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:12120962-12120984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:12120962-12120984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:12120962-12120984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:12120962-12120984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:12120962-12120984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
STAU1 hsa-miR-30e-3p low: 0 high: 7 4 5 4 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr20:49166241-49166265 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr20:49114829-49114845 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr20:49114829-49114845 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:49114829-49114845 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr20:49114829-49114845 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:49114829-49114845 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr20:49114061-49114087 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CSDE1 hsa-miR-30e-3p low: 0 high: 7 1 1 1 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:114749874-114749894 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:114749874-114749894 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:114749874-114749894 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:114749846-114749863 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:114749846-114749863 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:114749846-114749863 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:114749846-114749863 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BRWD1 hsa-miR-30e-3p low: 0 high: 7 4 4 4 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr21:39196203-39196226 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr21:39195066-39195084 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr21:39196203-39196226 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr21:39195066-39195084 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr21:39196203-39196226 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr21:39195066-39195084 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr21:39278788-39278811 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RAPGEF2 hsa-miR-30e-3p low: 0 high: 6 5 6 4 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr4:159359440-159359467 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr4:159359440-159359467 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr4:159359440-159359467 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr4:159359183-159359205 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Hafner M. et al. 2010 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN PAR-CLIP POSITIVE DIRECT TarBase 6.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr4:159359440-159359467 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MTHFD2 hsa-miR-30e-3p low: 0 high: 6 5 4 4 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr2:74214919-74214942 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr2:74214323-74214339 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Sebastian Memczak et al. 2013 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:74214323-74214339 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr2:74214323-74214339 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:74214323-74214339 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:74214323-74214339 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MNT hsa-miR-30e-3p low: 0 high: 6 4 4 4 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr17:2384094-2384118 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:2384316-2384339 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:2384078-2384101 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:2384094-2384118 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:2384094-2384118 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:2384078-2384101 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNRC6A hsa-miR-30e-3p low: 0 high: 6 5 5 5 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr16:24789968-24789990 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:24789968-24789990 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:24816848-24816866 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr16:24789968-24789990 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24789631-24789652 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:24789631-24789652 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCNB1 hsa-miR-30e-3p low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:69175494-69175516 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:69175494-69175516 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:69175494-69175516 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:69175494-69175516 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:69175494-69175516 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:69175494-69175516 HITS-CLIP POSITIVE DIRECT TarBase 7.0
VPS37A hsa-miR-30e-3p low: 0 high: 6 3 3 2 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr8:17295174-17295195 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr8:17295174-17295195 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:17295174-17295195 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:17295174-17295195 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:17295174-17295195 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:17295174-17295195 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NRARP hsa-miR-30e-3p low: 0 high: 6 2 2 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr9:137300869-137300890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr9:137300869-137300890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr9:137300869-137300890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:137300869-137300890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr9:137300869-137300890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Hafner M. et al. 2010 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN PAR-CLIP POSITIVE DIRECT TarBase 6.0
KPNA2 hsa-miR-30e-3p low: 0 high: 5 4 5 5 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr17:68046692-68046715 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Bone Marrow C8166 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:68046692-68046715 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:68046692-68046715 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr17:68046692-68046715 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:68046692-68046715 PAR-CLIP POSITIVE DIRECT TarBase 7.0
KMT2C hsa-miR-30e-3p low: 0 high: 5 2 2 2 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr7:152136411-152136431 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:152136411-152136431 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr7:152136411-152136431 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:152136294-152136318 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr7:152203007-152203030 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUCKS1 hsa-miR-30e-3p low: 0 high: 5 2 2 2 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:205718001-205718013 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:205719568-205719587 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:205718001-205718013